[Sinphar] May 2026 Revenue Reaches NT$301 Million (+10.3% YoY)
Sinphar (TWSE: 1734), a biotech and medical company, reported May 2026 consolidated revenue of NT$300.796 million (approx. NT$301 million), representing a 10.3% increase year-on-year.
📋 Article Processing Timeline
- 📰 Published: May 1, 2026 at 09:00
- 🔍 Collected: June 12, 2026 at 08:00 (1007h 0m after Published)
- 🤖 AI Analyzed: June 12, 2026 at 16:43 (8h 43m after Collected)
Sinphar (Company Code: 1734), operating in the biotechnology and medical industry, announced its financial results for May 2026.
The company's revenue for the month stood at NT$300,796 thousand (approximately NT$301 million). This mark represents a solid 10.3% increase compared to the same month last year.
The company's revenue for the month stood at NT$300,796 thousand (approximately NT$301 million). This mark represents a solid 10.3% increase compared to the same month last year.
FAQ
What was Sinphar's revenue in May 2026?
Sinphar's revenue for May 2026 was NT$300,796 thousand (approximately NT$301 million).
How did Sinphar's May 2026 revenue compare to the previous year?
It grew by 10.3% compared to the same month in the previous year.
What is Sinphar's industry classification?
It belongs to the biotechnology and medical industry (biotech sector).